Nisoldipine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

11 Suppliers, 8 USDMF, 2 JDMF, 1 EU WC, 2 NDC API, 4 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

19 Dossiers, 16 FDA Orange Book, 1 Europe, 2 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 17MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 34MG, TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8.5MG

RELATED EXCIPIENT COMPANIES

Suppliers, 28 Kerry, 23 BASF, 11 Corel Pharma Chem, 9 Microlex e.U, 8 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Seppic, 5 Gangwal Chemicals, 5 Gangwal Healthcare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Kima Chemical, 3 Roquette, 3 Actylis, 3 Sigachi Industries, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Nomisma Healthcare, 2 DFE Pharma, 2 Seqens, 2 Evonik, 2 The Dow Chemical Company, 1 Pharmatrans-Sanaq, 1 Boai NKY Pharmaceuticals Ltd, 1 Finar, 1 Prachin Chemical, 1 Nanjing Well Pharmaceutical, 1 Vasa Pharmachem, 1 Ulanqab Kema New Material, 1 ACG Worldwide, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

48 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 29 Controlled & Modified Release, 14 Granulation, 14 Direct Compression, 13 Solubilizers, 11 Lubricants & Glidants, 9 Film Formers & Plasticizers, 8 Co-Processed Excipients, 8 Topical, 8 Thickeners and Stabilizers, 5 Parenteral, 5 Empty Capsules, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Emulsifying Agents, 2 Coloring Agents, 1 Chewable & Orodispersible Aids, 1 Rheology Modifiers

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 1 Finished Drug Prices

REF. STANDARDS & IMPURITIES

5 Others

5 Others

DIGITAL CONTENT

1 News

1 News

Pharmacy pricing data of Nisoldipine obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Nisoldipine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

11 Suppliers

8 USDMF

2 JDMF

1 EU WC

2 NDC API

4 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

19 Dossiers

16 FDA Orange Book

1 Europe

2 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 17MG

TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 34MG

TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 8.5MG

RELATED EXCIPIENT COMPANIES

Suppliers

28 Kerry

23 BASF

11 Corel Pharma Chem

9 Microlex e.U

8 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Seppic

5 Gangwal Chemicals

5 Gangwal Healthcare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Kima Chemical

3 Roquette

3 Actylis

3 Sigachi Industries

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Nomisma Healthcare

2 DFE Pharma

2 Seqens

2 Evonik

2 The Dow Chemical Company

1 Pharmatrans-Sanaq

1 Boai NKY Pharmaceuticals Ltd

1 Finar

1 Prachin Chemical

1 Nanjing Well Pharmaceutical

1 Vasa Pharmachem

1 Ulanqab Kema New Material

1 ACG Worldwide

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

48 Coating Systems & Additives

35 Fillers, Diluents & Binders

29 Controlled & Modified Release

14 Granulation

14 Direct Compression

13 Solubilizers

11 Lubricants & Glidants

9 Film Formers & Plasticizers

8 Co-Processed Excipients

8 Topical

8 Thickeners and Stabilizers

5 Parenteral

5 Empty Capsules

4 Disintegrants & Superdisintegrants

4 Vegetarian Capsules

4 API Stability Enhancers

4 Taste Masking

TABLET, EXTENDED RELEASE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 25.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons